Inapsine

Inapsine is a brand name of droperidol, approved by the FDA in the following formulation(s):

INAPSINE (droperidol - injectable; injection)

• 
  Manufacturer: AKORN INC
  
  Approved Prior to Jan 1, 1982
  
  Strength(s): 2.5MG/ML ^[RLD][AP]

Has a generic version of Inapsine been approved?

Yes. The following products are equivalent to Inapsine:

droperidol injectable; injection

• 
  Manufacturer: HOSPIRA
  
  Approval date: February 29, 1988
  
  Strength(s): 2.5MG/ML ^[AP]


• 
  Manufacturer: LUITPOLD
  
  Approval date: October 24, 1988
  
  Strength(s): 2.5MG/ML ^[AP]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Inapsine. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Inapsine.

See also...

• Inapsine Consumer Information (Wolters Kluwer)
• Inapsine Consumer Information (Cerner Multum)
• Inapsine Advanced Consumer Information (Micromedex)
• Inapsine AHFS DI Monographs (ASHP)
• Droperidol Consumer Information (Wolters Kluwer)
• Droperidol Consumer Information (Cerner Multum)
• Droperidol Injection Advanced Consumer Information (Micromedex)
• Droperidol AHFS DI Monographs (ASHP)